Worldwide Epidemiology of Fibromyalgia

  • Luiz Paulo QueirozEmail author
Fibromyalgia (M Peres, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Fibromyalgia


Studying the epidemiology of fibromyalgia (FM) is very important to understand the impact of this disorder on persons, families and society. The recent modified 2010 classification criteria of the American College of Rheumatology (ACR), without the need of tender points palpation, allows that larger and nationwide surveys may be done, worldwide. This article reviews the prevalence and incidence studies done in the general population, in several countries/continents, the prevalence of FM in special groups/settings, the association of FM with some sociodemographic characteristics of the population, and the comorbidity of FM with others disorders, especially with headaches.


Epidemiology Prevalence Fibromyalgia Chronic widespread pain Chronic pain Headache 


Compliance with Ethics Guidelines

Conflict of Interest

Dr. Luiz Paulo Queiroz reported no potential conflicts of interest relevant to this article.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of great importance

  1. 1.
    Harstall C, Ospina M. How prevalent is chronic pain? Pain Clinical Updates [Internet]. 2003, 11:1–4. Available at Accessed April 2013.
  2. 2.
    Azevedo L, Costa-Pereira A, Mendonça L, et al. Epidemiology of chronic pain: a population-based nationwide study on its prevalence, characteristics and associated disability in Portugal. J Pain. 2012;13:773–83.PubMedCrossRefGoogle Scholar
  3. 3.
    Ablin J, Oren A, Cohen S, et al. Prevalence of fibromyalgia in the Israeli population: a population-based study to estimate the prevalence of fibromyalgia in the Israeli population using the London Fibromyalgia Epidemiology Study Screening Questionnaire (LFESSQ). Clin Exp Rheumatol. 2012;30 Suppl 74:39–43.PubMedGoogle Scholar
  4. 4.
    Neumann L, Buskila D. Epidemiology of fibromyalgia. Curr Pain Headache Rep. 2003;7:362–8.PubMedCrossRefGoogle Scholar
  5. 5.
    White K, Harth M. Classification, epidemiology, and natural history of fibromyalgia. Curr Pain Headache Rep. 2001;5:320–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Wolfe F, Smythe HA, Yunus M, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum. 1990;33:160–72.PubMedCrossRefGoogle Scholar
  7. 7.
    • Wolfe F, Clauw D, Fitzcharles M, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62:600–10. A change in the concept of FM, excluding tender points sites palpation as an essential diagnostic criterion to make this diagnosis. CrossRefGoogle Scholar
  8. 8.
    •• Wolfe F, Clauw D, Fitzcharles M, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011;38:1113–22. A revision of the 2010 diagnostic criteria, developing a survey questionnaire for epidemiological and clinical studies. PubMedCrossRefGoogle Scholar
  9. 9.
    Guermazi M, Ghroubi S, Sellami M, et al. Fibromyalgia prevalence in Tunisia. Tunis Med. 2008;86:806–11.PubMedGoogle Scholar
  10. 10.
    Senna E, De Barros A, Silva E, et al. Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol. 2004;31:594–7.PubMedGoogle Scholar
  11. 11.
    White K, Speechley M, Harth M, Ostbye T. The London fibromyalgia epidemiology study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol. 1999;26:1570–6.PubMedGoogle Scholar
  12. 12.
    McNally J, Matheson D, Bakowsky V. The epidemiology of self-reported fibromyalgia in Canada. Chronic Dis Can. 2006;27:9–16.PubMedGoogle Scholar
  13. 13.
    Wolfe F, Ross K, Anderson J, et al. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38:19–28.PubMedCrossRefGoogle Scholar
  14. 14.
    • Vincent A, Lahr B, Wolfe F, et al. Prevalence of fibromyalgia: a population-based study in Olmsted county, Minnesota, utilizing the Rochester epidemiology project. Arthritis Care Res. 2013;65:786–92. A recent epidemiological study, using the 2010 ACR diagnostic criteria for FM. CrossRefGoogle Scholar
  15. 15.
    Haq S, Darmawan J, Islam M, et al. Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study. J Rheumatol. 2005;32:348–53.PubMedGoogle Scholar
  16. 16.
    Scudds R, Li E, Scudds R. The prevalence of fibromyalgia syndrome in Chinese people in Hong Kong. J Musculoskelet Pain. 2006;14:3–11.CrossRefGoogle Scholar
  17. 17.
    Veerapen K, Wigley R, Valkenburg H. Musculoskeletal pain in Malaysia: a COPCORD survey. J Rheumatol. 2007;34:207–13.PubMedGoogle Scholar
  18. 18.
    Farooqi A, Gibson T. Prevalence of the major rheumatic disorders in the adult population of north Pakistan. Rheumatology. 1998;37:491–5.CrossRefGoogle Scholar
  19. 19.
    Prateepavanich P, Petcharapiruch S, Leartsakulpanitch J. Estimating the prevalence of fibromyalgia and its impacts on health in thais: a community-survey in Bangkok, Thailand [Abstract]. Value in Health. 2012;15:A678.CrossRefGoogle Scholar
  20. 20.
    Prescott E, Kjøller M, Jacobsen S, et al. Fibromyalgia in the adult Danish population: I. A prevalence study. Scand J Rheumatol. 1993;22:233–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Bannwarth B, Blotman F, Roué-Le Lay K, et al. Fibromyalgia syndrome in the general population of France: a prevalence study. Joint Bone Spine. 2009;76:184–7.PubMedCrossRefGoogle Scholar
  22. 22.
    • Perrot S, Vicaut E, Servant D, Ravaud P. Prevalence of fibromyalgia in France: a multi-step study research combining national screening and clinical confirmation: the DEFI study (Determination of Epidemiology of Fibromyalgia). BMC Musculoskelet Disord. 2011;12:224–32. A nationwide epidemiological study of FM in France. PubMedCrossRefGoogle Scholar
  23. 23.
    Mäkelä M, Heliövaara M. Prevalence of primary fibromyalgia in the Finnish population. BMJ. 1991;303:216–9.PubMedCrossRefGoogle Scholar
  24. 24.
    • Branco J, Bannwarth B, Failde I, et al. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum. 2010;39:448–53. A large, nationwide epidemiological study of FM in France, Germany, Italy, Portugal, and Spain. PubMedCrossRefGoogle Scholar
  25. 25.
    • Wolfe F, Brähler E, Hinz A, Häuser W. Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res. 2013;65:777–85. A large, nationwide epidemiological study of FM in Germany, using the 2010 ACR diagnostic criteria for FM. CrossRefGoogle Scholar
  26. 26.
    Andrianakos A, Trontzas P, Christoyannis F, et al. Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study. The ESORDIG Study. J Rheumatol. 2003;30:1589–601.PubMedGoogle Scholar
  27. 27.
    Salaffi F, De Angelis R, Grassi W, et al. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol. 2005;23:819–28.PubMedGoogle Scholar
  28. 28.
    Mas A, Carmona L, Valverde M, et al. Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain. Clin Exp Rheumatol. 2008;2:519–26.Google Scholar
  29. 29.
    Lindell L, Bergman S, Petersson I, et al. Prevalence of fibromyalgia and chronic widespread pain. Scand J Prim Health Care. 2000;18:149–53.PubMedCrossRefGoogle Scholar
  30. 30.
    Turhanoglu A, Yilmaz S, Kaya S, et al. The epidemiological aspects of fibromyalgia syndrome in adults living in turkey: a population based study. J Musculoskelet Pain. 2008;16:141–7.CrossRefGoogle Scholar
  31. 31.
    Forseth K, Gran J. The prevalence of fibromyalgia among women aged 20–49 years in Arendal, Norway. Scand J Rheumatol. 1992;21:74–8.PubMedCrossRefGoogle Scholar
  32. 32.
    Topbas M, Cakirbay H, Gulec H, et al. The prevalence of fibromyalgia in women aged 20–64 in Turkey. Scand J Rheumatol. 2005;34:140–4.PubMedGoogle Scholar
  33. 33.
    Clark P, Burgos-Vargas R, Medina-Palma C, et al. Prevalence of fibromyalgia in children: a clinical study of Mexican children. J Rheumatol. 1998;25:2009–14.PubMedGoogle Scholar
  34. 34.
    Barsante Santos A, Schulze Burti J, Lopes J, et al. Prevalence of fibromyalgia and chronic widespread pain in community-dwelling elderly subjects living in São Paulo, Brazil. Maturitas. 2010;67:251–5.CrossRefGoogle Scholar
  35. 35.
    Kim C, Kim H, Kim J. Prevalence of chronic widespread pain and fibromyalgia syndrome: a Korean hospital-based study. Rheumatol Int. 2012;32:3435–42.PubMedCrossRefGoogle Scholar
  36. 36.
    Gallinaro A, Feldman D, Natour J. An evaluation of the association between fibromyalgia and repetitive strain injuries in metalworkers of an industry in Guarulhos, Brazil. Joint Bone Spine. 2001;68:59–64.PubMedCrossRefGoogle Scholar
  37. 37.
    Cobankara V, Unal U, Kaya A, et al. The prevalence of fibromyalgia among textile workers in the city of Denizli in Turkey. Int J Rheum Dis. 2011;14:390–4.PubMedCrossRefGoogle Scholar
  38. 38.
    Toda K. The prevalence of fibromyalgia in Japanese workers. Scand J Rheumatol. 2007;36:140–4.PubMedCrossRefGoogle Scholar
  39. 39.
    White K, Thompson J. Fibromyalgia syndrome in an Amish community: a controlled study to determine disease and symptom prevalence. J Rheumatol. 2003;30:1835–40.PubMedGoogle Scholar
  40. 40.
    Assumpção A, Cavalcante A, Capela C, et al. Prevalence of fibromyalgia in a low socioeconomic status population. BMC Musculoskelet Disord. 2009;10:64–70.PubMedCrossRefGoogle Scholar
  41. 41.
    Sauer K, Kemper C, Glaeske G. Fibromyalgia syndrome: prevalence, pharmacological and non-pharmacological interventions in outpatient health care. An analysis of statutory health insurance data. Joint Bone Spine. 2011;78:80–4.PubMedCrossRefGoogle Scholar
  42. 42.
    Forseth K, Gran J, Husby G. A population study of the incidence of fibromyalgia among women aged 26–55 yr. Rheumatology. 1997;36:1318–23.CrossRefGoogle Scholar
  43. 43.
    Weir P, Harlan G, Nkoy F, et al. The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codes. J Clin Rheumatol. 2006;12:124–8.PubMedCrossRefGoogle Scholar
  44. 44.
    Castells X, Coscolla R, Sunyol R, et al. “ESTUDI EPIFFAC” Impacto Familiar, Socio-Laboral y Económico de Padecer Fibromialgia. Available at Accessed April 2013
  45. 45.
    Haviland M, Banta J, Przekop P. Fibromyalgia: prevalence, course, and co-morbidities in hospitalized patients in the United States, 1999–2007. Clin Exp Rheumatol. 2011;29 Suppl 69:S79–87.PubMedGoogle Scholar
  46. 46.
    Wolfe F, Michaud K, Li T, Katz R. Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia. J Rheumatol. 2010;37:305–15.PubMedCrossRefGoogle Scholar
  47. 47.
    Schur E, Olarte M, Sullivan P, Buchwald D. Feeling bad in more ways than one: comorbidity patterns of medically unexplained and psychiatric conditions. J Gen Intern Med. 2007;22:818–21.PubMedCrossRefGoogle Scholar
  48. 48.
    Peres M, Young W, Kaup A, et al. Fibromyalgia is common in patients with transformed migraine. Neurology. 2001;57:1326–8.PubMedCrossRefGoogle Scholar
  49. 49.
    Ifergane G, Buskila D, Simiseshvely N, et al. Prevalence of fibromyalgia syndrome in migraine patients. Cephalalgia. 2006;26:451–6.PubMedCrossRefGoogle Scholar
  50. 50.
    de Tommaso M, Sardaro M, Serpino C, et al. Fibromyalgia comorbidity in primary headaches. Cephalalgia. 2009;29:453–64.PubMedCrossRefGoogle Scholar
  51. 51.
    • de Tommaso M, Federici A, Serpino C, et al. Clinical features of headache patients with fibromyalgia comorbidity. J Headache Pain. 2011;12:629–38. A large study about the association of some primary headaches with FM. PubMedCrossRefGoogle Scholar
  52. 52.
    Tietjen G, Brandes J, Peterlin B, et al. Allodynia in migraine: association with comorbid pain conditions. Headache. 2009;49:1333–44.PubMedCrossRefGoogle Scholar
  53. 53.
    Tietjen G, Herial N, Hardgrove J, et al. Migraine comorbidity constellations. Headache. 2007;47:857–65.PubMedCrossRefGoogle Scholar
  54. 54.
    • Le H, Tfelt-Hansen P, Russell M, et al. Co-morbidity of migraine with somatic disease in a large population-based study. Cephalalgia. 2011;31:43–64. A large study of the migraine comorbidity, including FM, in twin cohort of Denmark. PubMedCrossRefGoogle Scholar
  55. 55.
    Küçüksen S, Genç E, Yilmaz H, et al. The prevalence of fibromyalgia and its relation with headache characteristics in episodic migraine. Clin Rheumatol 2013 Feb 27, Epub ahead of print.Google Scholar
  56. 56.
    Aaron L, Burke M, Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med. 2000;160:221–7.PubMedCrossRefGoogle Scholar
  57. 57.
    Marcus D, Bernstein C, Rudy T. Fibromyalgia and headache: an epidemiological study supporting migraine as part of the fibromyalgia syndrome. Clin Rheumatol. 2005;24:595–601.PubMedCrossRefGoogle Scholar
  58. 58.
    Ravindran M, Zheng Y, Timbol C, et al. Migraine headaches in chronic fatigue syndrome (CFS): comparison of two prospective cross-sectional studies. BMC Neurol. 2011;11:30–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of NeurologyUniversidade Federal de Santa CatarinaFlorianópolisBrazil

Personalised recommendations